162 related articles for article (PubMed ID: 31693984)
1. Contribution of Geographic Location to Disparities in Ovarian Cancer Treatment.
Villanueva C; Chang J; Bartell SM; Ziogas A; Bristow R; Vieira VM
J Natl Compr Canc Netw; 2019 Nov; 17(11):1318-1329. PubMed ID: 31693984
[TBL] [Abstract][Full Text] [Related]
2. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.
Bristow RE; Chang J; Ziogas A; Anton-Culver H; Vieira VM
Gynecol Oncol; 2014 Jul; 134(1):60-7. PubMed ID: 24680770
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer in California: Guideline adherence, survival, and the impact of geographic location, 1996-2014.
Villanueva C; Chang J; Ziogas A; Bristow RE; Vieira VM
Cancer Epidemiol; 2020 Dec; 69():101825. PubMed ID: 33022472
[TBL] [Abstract][Full Text] [Related]
4. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
5. Spatial-Temporal Trends in Ovarian Cancer Outcomes in California.
Villanueva C; Chang J; Ziogas A; Bristow RE; Vieira VM
JNCI Cancer Spectr; 2022 Nov; 6(6):. PubMed ID: 36238987
[TBL] [Abstract][Full Text] [Related]
6. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
[TBL] [Abstract][Full Text] [Related]
7. Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.
Hodeib M; Chang J; Liu F; Ziogas A; Dilley S; Randall LM; Anton-Culver H; Bristow RE
Gynecol Oncol; 2015 Jul; 138(1):121-7. PubMed ID: 25913132
[TBL] [Abstract][Full Text] [Related]
8. Spatial analysis of advanced-stage ovarian cancer mortality in California.
Bristow RE; Chang J; Ziogas A; Gillen DL; Bai L; Vieira VM
Am J Obstet Gynecol; 2015 Jul; 213(1):43.e1-43.e8. PubMed ID: 25644440
[TBL] [Abstract][Full Text] [Related]
9. A Risk-Adjusted Model for Ovarian Cancer Care and Disparities in Access to High-Performing Hospitals.
Bristow RE; Chang J; Villanueva C; Ziogas A; Vieira VM
Obstet Gynecol; 2020 Feb; 135(2):328-339. PubMed ID: 31923082
[TBL] [Abstract][Full Text] [Related]
10. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System.
Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
[TBL] [Abstract][Full Text] [Related]
11. Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California.
Pfaendler KS; Chang J; Ziogas A; Bristow RE; Penner KR
Obstet Gynecol; 2018 May; 131(5):899-908. PubMed ID: 29630020
[TBL] [Abstract][Full Text] [Related]
12. The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.
Joslin CE; Brewer KC; Davis FG; Hoskins K; Peterson CE; Pauls HA
Gynecol Oncol; 2014 Nov; 135(2):285-91. PubMed ID: 25173584
[TBL] [Abstract][Full Text] [Related]
13. Disparities in Receipt of National Comprehensive Cancer Network Guideline-Adherent Care and Outcomes among Women with Triple-Negative Breast Cancer by Race/Ethnicity, Socioeconomic Status, and Insurance Type.
Ubbaonu CD; Chang J; Ziogas A; Mehta RS; Kansal KJ; Zell JA
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067290
[TBL] [Abstract][Full Text] [Related]
14. Racial and socioeconomic disparities in adherence to preventive health services for ovarian cancer survivors.
Loomer L; Ward KC; Reynolds EA; von Esenwein SA; Lipscomb J
J Cancer Surviv; 2019 Aug; 13(4):512-522. PubMed ID: 31172430
[TBL] [Abstract][Full Text] [Related]
15. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
Bristow RE; Chang J; Ziogas A; Randall LM; Anton-Culver H
Gynecol Oncol; 2014 Feb; 132(2):403-10. PubMed ID: 24361578
[TBL] [Abstract][Full Text] [Related]
16. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
17. Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist Consultation.
Gupta A; Chen Q; Wilson LE; Huang B; Pisu M; Liang M; Previs RA; Moss HA; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
JAMA Netw Open; 2023 Feb; 6(2):e2254595. PubMed ID: 36723938
[TBL] [Abstract][Full Text] [Related]
18. Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California.
Parise CA; Bauer KR; Caggiano V
Cancer; 2012 May; 118(9):2516-24. PubMed ID: 21918967
[TBL] [Abstract][Full Text] [Related]
19. Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers.
Alvarez E; Keegan T; Johnston EE; Haile R; Sanders L; Saynina O; Chamberlain LJ
Cancer; 2017 Jul; 123(13):2516-2523. PubMed ID: 28241089
[TBL] [Abstract][Full Text] [Related]
20. Socioeconomic and racial disparities in the selection of chest wall boost radiation therapy in californian women after mastectomy.
Hess C; Lee A; Fish K; Daly M; Cress RD; Mayadev J
Clin Breast Cancer; 2015 Jun; 15(3):212-8. PubMed ID: 25499694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
